Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreencore Regulatory News (GNC)

Share Price Information for Greencore (GNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.80
Bid: 0.00
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 17.80 (13.464%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 132.80
GNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY22 Q4 and Full Year Trading Update

11 Oct 2022 07:00

RNS Number : 4087C
Greencore Group PLC
11 October 2022
 

11 October 2022

Greencore Group plc

Full Year and Q4 Trading Update for the Year ended 30 September 2022

Satisfactory year on year earnings progression and further deleveraging

Greencore Group plc ("Greencore" or the "Group") a leading manufacturer of convenience foods in the UK, today issues a trading update for Q4 and the full year ended 30 September 2022, ahead of the publication of its full year results on 29 November 2022.

Highlights1, 2

· Progressive year on year improvement in revenue, Operating Profit and deleveraging, supported by continued volume growth and significant recovery of inflation

· FY22 reported revenue of approximately £1.7bln (FY21: £1.3bln)

· FY22 Adjusted Operating Profit and Adjusted EPS at the lower end of the respective ranges of £72-£77m and 9.2p-10.0p (given in the Q3 22 update on 26 July) after absorbing the impact on volume and operations of rail strikes and the unscheduled bank holiday in September 2022

· Strong cash conversion resulting in Net Debt (excluding lease liabilities) of approximately £180m (2021: £183m) at year end after £30m strategic capex and most of the £10m share buyback, with Net Debt:EBITDA, as measured under financing agreements, approaching the Group's target range of 1.0x - 1.5x

· Q4 Pro-forma revenue 25% up year on year due to the impact of inflation recovery and new business wins

 

 

Pro Forma Revenue Growth

Q4

Versus Q4 2021

FY22

Versus

FY21

Group

25%

29%

Food to go categories

23%

35%

Other convenience food categories

29%

19%

 

 

Trading Performance

Pro forma revenue growth in Q4 22 of 25% year on year is driven by a combination of increased volumes, a low-teen percentage increase in underlying pricing, the onboarding of new business in ready meals and increased revenue in the Group's Irish ingredients trading business.

 

Q4 22 revenue growth of 23% in food to go categories is lower than Q3 22 due to a stronger comparative period, the volume impact of rail strikes and the unexpected bank holiday, and the full year effect of new business wins in Q4 21. In Q4 22, we completed the onboarding of new business enabled by the £30m strategic capital investment across three manufacturing sites.

 

For the full year, we have delivered good year on year volume growth while recovering significant levels of ongoing inflation and enhancing profit and cash conversion. Group pro forma revenue has increased 29% year on year with a 35% increase in food to go categories reflecting volume growth, the onboarding of new business and the impact of inflation recovery.

 

Adjusted Operating Profit will be at the lower end of the range of £72-£77m (given in the Q3 22 update on 26 July) after absorbing the impact on volume and operations in Q4 22 of rail strikes and the additional September bank holiday.

 

We have also retained our focus on tight cashflow management delivering an absolute reduction in Net Debt year on year at the same time as delivering our share buyback programme. Net debt was approximately £180m at the end of the financial year marginally down from £183m in 2021. Leverage is now approaching our target range of 1.0x to 1.5x.

 

The £10m share buyback programme that commenced on 26 July 2022, the first phase of our previously announced £50m value return to shareholders over the coming two years, has now been completed, as announced on 7 October 2022.

 

Outlook

We closely monitor the impact of the UK macroeconomic environment on consumer sentiment and demand in our categories. We don't currently see an impact as consumer demand has held up well, however we remain watchful and cautious about the potential impact of cost-of-living factors through the year ahead. 

 

We remain focused on the recovery of inflation through all mechanisms available and are working with our customers and supply partners to mitigate the ongoing impact of the persistently high inflation across the industry on consumer prices. We have substantially recovered the inflation that we have experienced over the last 12 months, and we are making decisions whether to bid for or renew contracts based on their economics, including the ability to recover inflation.  

 

We remain focused on execution of our Better Greencore efficiency programme and continue to plan for the second phase which focuses on output optimization and efficiency.

 

For further information, please contact:

Dalton Philips

Chief Executive Officer

Tel: +353 (0) 1 486 3326

Emma Hynes

Chief Financial Officer

Tel: +353 (0) 1 486 3307

Rob Greening/Nick Hayns

Powerscourt

Tel: +44 (0) 20 7250 1446

Billy Murphy / Claire Rowley

Drury | Porter Novelli

Tel: +353 (0) 87 231 3085) / +353 (0)87 269 5014

 

 

 

Unaudited

2 Pro forma references throughout this statement are on a constant currency basis and exclude the impact of the 53rd week in 2022.

 

About Greencore

Greencore is a leading manufacturer of convenience food in the UK. It supplies grocery and other retailers including all of the major UK supermarkets. The Group has strong market positions in a range of categories including sandwiches, salads, sushi, chilled snacking, chilled ready meals, chilled soups and sauces, chilled quiche, ambient sauces and pickles, and frozen Yorkshire Puddings.

For further information go to www.greencore.com or follow Greencore on social media.

Financial information relating to Greencore Group plc in this announcement are not statutory financial statements within the meaning of Section 340 of the Companies Act 2014 of Ireland and have been published for the purposes of updating investors on financial performance for the periods referenced in this announcement. The statutory financial statements for the year ended 29 September 2022 have not been prepared or reported on by the statutory auditors, and are expected to be delivered to the Registrar of Companies of Ireland within 28 days of [ February].

Certain statements made in this announcement are forwardlooking. These represent expectations for the Group's business, and involve known and unknown risks and uncertainties, many of which are beyond the Group's control. The Group has based these forwardlooking statements on current expectations and projections about future events. These forward-looking statements may generally, but not always, be identified by the use of words such as 'will', 'aims', 'anticipates', 'continue', 'could', 'should', 'expects', 'is expected to', 'may', 'estimates', 'believes', 'intends', 'projects', 'targets', or the negative thereof, or similar expressions.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect the Group's current expectations and assumptions as to such future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by forward-looking statements. You should not place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this announcement. The Group expressly disclaims any obligation to publicly update or review these forward-looking statements other than as required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBBLLFLBLBFBZ
Date   Source Headline
30th Apr 202412:34 pmRNSTotal Voting Rights
28th Mar 20242:44 pmRNSTotal Voting Rights
28th Mar 20242:44 pmRNSBlock listing Interim Review
28th Mar 20242:40 pmRNSHolding(s) in Company
25th Mar 20244:29 pmRNSDirector/PDMR Shareholding
29th Feb 20244:31 pmRNSTotal Voting Rights
23rd Feb 20247:01 amRNSCompletion of Share Buyback
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 202412:09 pmRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:05 amRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20244:26 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20242:15 pmRNSResult of AGM
25th Jan 20247:01 amRNSChanges to Board Roles and Committee Composition
25th Jan 20247:00 amRNSFY24 Q1 Trading Update
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20242:46 pmRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20244:07 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.